Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (116)
2025 (1325)
2024 (1331)
2023 (1277)
2022 (1392)
2021 (1425)
2020 (1224)
2019 (1083)
2018 (1143)
2017 (1036)
2016 (936)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (14812)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Jernbom Falk A
JSON
CSV
XLSX
TXT
Family name
Jernbom Falk
Given name
August
Initials
A
ORCID
ORCID
0000-0002-7773-1851
Affiliations
Department of Protein Science Division of Protein Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
12 publications
PubMed
DOI
Crossref
Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor.
Hong X
,
Nadeau KC
,
Frischmeyer-Guerrerio P
, ..., Ji H, Wang X
Allergy
81
(1) 197-208 [2026-01-00; online 2025-11-27]
PubMed
DOI
Crossref
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19.
Jernbom AF
,
Skoglund L
,
Pin E
, ...,
Månberg A
,
Nilsson P
Nat Commun
15
(1) 8941 [2024-10-17; online 2024-10-17]
DOI
Crossref
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
Jernbom Falk A
, Skoglund L, Pin E, ..., Månberg A,
Nilsson P
-
-
(-) - [2024-02-15; online 2024-02-15]
PubMed
DOI
Crossref
Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.
Oraki Kohshour M
,
Kannaiyan NR
,
Falk AJ
, ...,
Nilsson P
, Schulze TG
Transl Psychiatry
12
(1) 471 [2022-11-09; online 2022-11-09]
PubMed
DOI
Crossref
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
Laurén I
, Havervall S,
Ng H
, ..., Thålin C,
Mangsbo S
Immun Inflamm Dis
10
(4) e595 [2022-04-00; online 2022-03-30]
Gustaf Christoffersson
SciLifeLab Fellow
PubMed
DOI
Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
Havervall S,
Jernbom Falk A
,
Klingström J
, ...,
Nilsson P
, Thålin C
PLoS ONE
17
(1) e0262169 [2022-01-12; online 2022-01-12]
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J. Intern. Med.
291
(1) 72-80 [2022-01-00; online 2021-09-27]
PubMed
DOI
Crossref
Multiomics Profiling of Alzheimer's Disease Serum for the Identification of Autoantibody Biomarkers.
San Segundo-Acosta P, Montero-Calle A,
Jernbom-Falk A
, ..., Nilsson P,
Barderas R
J. Proteome Res.
20
(11) 5115-5130 [2021-11-05; online 2021-10-10]
PubMed
DOI
Crossref
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
Mangsbo SM
, Havervall S, Laurén I, ..., Klingström J, Thålin C
PLoS ONE
16
(9) e0258041 [2021-09-30; online 2021-09-30]
Gustaf Christoffersson
SciLifeLab Fellow
PubMed
DOI
Crossref
Autoantibody profiles associated with clinical features in psychotic disorders.
Jernbom Falk A
,
Galletly C
,
Just D
, ...,
Månberg A
,
Schubert KO
Transl Psychiatry
11
(1) 474 [2021-09-13; online 2021-09-13]
PubMed
DOI
Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S
, Hellström C,
Olofsson J
, ...,
Hedhammar M
,
Nilsson P
Clin Transl Immunology
10
(7) e1312 [2021-07-19; online 2021-07-19]
PubMed
DOI
Crossref
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Rudberg AS
, Havervall S,
Månberg A
, ...,
Hober S
,
Thålin C
Nat Commun
11
(1) 5064 [2020-10-08; online 2020-10-08]
SciLifeLab Data Centre
Publications
9.5.1